欧洲专家实验室寨卡病毒分子检测灵敏度差异:2016年11月外部质量评估
该研究通过外部质量评估方案,向50个欧洲实验室发放含寨卡病毒、登革病毒、黄热病毒或基孔肯雅病毒的12份样本,评估其分子检测能力。结果显示仅40%实验室(20/50)的所有核心样本检测正确,检测灵敏度差异大,需改进核酸提取和寨卡病毒检测方法。
要点
- 仅40%参与实验室能正确检出所有核心样本。
- 检测特异性较稳定,但灵敏度差异大。
- 改进应聚焦核酸提取与寨卡病毒检测方法。
核心结论
- 60%的参与实验室需改进寨卡病毒分子检测能力。
研究设计与样本
- 外部质量评估方案,50个实验室来自31个国家,共提交85份面板结果;样本含阴性、非洲或亚洲 lineage 寨卡病毒(10^3至10^9 copies/ml)、登革病毒、黄热病毒或基孔肯雅病毒。
主要发现
- 实验室层面仅40%(20/50)的实验室所有核心样本检测正确,覆盖45%的国家。
- 检测特异性较稳定,但灵敏度差异大。
关键数值与推荐
- 核心样本定义为超过50%实验室正确评分寨卡病毒RNA状态的样本。
- 所有样本均被指定为核心样本。
临床怎么用
- 实验室应优化核酸提取和寨卡病毒检测方法以缩小灵敏度差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Zika virus (ZIKV) infections are a significant public health concern. A strong capability for ZIKV detection is an absolute requirement for adequate preparedness and response strategies and individual patient care. The objective of this study was to assess and improve the capability of European expert laboratories for molecular testing for ZIKV through an external quality assessment (EQA) scheme. Laboratories were provided a panel of 12 samples which included negative samples, samples containing African- or Asian-lineage ZIKV at various concentrations (103 to 109 copies/ml), and samples containing dengue virus, yellow fever virus, or chikungunya virus. The results were analyzed on the basis of the outcomes of testing for the samples and the extraction and detection method used. Samples with a ZIKV RNA status scored correctly by >50% of the laboratories were designated the core sample. A total of 85 panel outcomes were submitted by 50 laboratories in 31 countries. The results designated all samples as core samples. Thirty-three percent (28/85) of the panel outcomes identified all samples. Analysis at the laboratory level showed that only 40% of the laboratories (20/50), representing 45% of the countries, scored sufficiently; i.e., they had at least one test operational that scored all core samples correctly. There is a need for improvement of the molecular detection of ZIKV in 60% of the participating laboratories. While the specificity of the tests was more robust, the results of the EQA showed large variation in test sensitivity. Improvements should focus on both nucleic acid extraction and ZIKV detection methods.
引用
- Charrel R, Mögling R, Pas S, et al. Variable Sensitivity in Molecular Detection of Zika Virus in European Expert Laboratories: External Quality Assessment, November 2016. J Clin Microbiol. 2017. PMID: 28835479. doi:10.1128/JCM.00987-17
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。